Abstract:BACKGROUND: Inflammatory responses in injured nerves have been recognized as important factors for initially sensitizing nociceptive neurons. Cyclooxygenase (COX) is the rate-limiting enzyme in prostaglandin synthesis, and COX-2 inhibitor is involved in mechanisms of analgesia and anti-inflammation.OBJECTIVE: To investigate the effects of COX-2 inhibitor on thermal and mechanical hyperalgesia, as well as expression of growth associated protein 43 (GAP-43) and nerve growth factor (NGF) in dorsal root ganglion, in a rat model of neuropathic pain due to chronic constriction injury.DESIGN, TIME AND SETTING: A randomized, controlled, comparison study that was performed at the Surgical Department and Pathological Laboratory, Second Affiliated Hospital of Shantou University Medical College from September 2006 to September 2007.MATERIALS: COX-2 inhibitor, lornoxicam, was purchased from Nycomed Pharmaceutical (Austria); rabbit anti-GAP-43, and rabbit anti-NGF polyclonal antibodies were purchased from Boster, Wuhan, China.METHODS: A total of 50 adult, Wistar rats were randomly assigned to four groups: normal control (n = 5), model (n = 15), normal saline control (n = 15), and lornoxicam treatment (n = 15). With exception of the control group, the sciatic nerve of all rats was loosely ligated to establish a model of chronic constriction injury. The model rats were divided into three subgroups according to varying post-operative survival periods: 3, 7 and 14 days (n = 5), respectively. Rats in the lornoxicam treatment group were intraperitoneally injected with 1.3 mg/kg lornoxicam every 12 hours throughout the entire experimental procedure. Rats in the normal saline control group were intraperitoneally injected with 1.3 mL/kg saline.MAIN OUTCOME MEASURES: Immunohistochemistry revealed expression of GAP-43 and NGF in the L5 dorsal root ganglions. Mechanical withdrawal threshold and thermal withdrawal latency were used to observe neurological behavioral changes in rats.RESULTS: The relative gray values of GAP-43- and NGF-positive neurons in the model group were remarkably increased compared with the normal control rats (P < 0.01), while the relative gray values in the lomoxicam treatment group were significantly less than the model and normal saline control groups (P < 0.01). Mechanical withdrawal threshold and thermal withdrawal latency gradually decreased with increasing injury time in the model, normal saline control, and lornoxicam treatment groups, and were significantly less than the normal control group (P < 0.05). In addition, mechanical withdrawal threshold and thermal Withdrawal latency were significantly greater in the lornoxicam treatment group compared with the model and normal saline control groups (P < 0.05).CONCLUSION: Intraperitoneal injection of the COX-2 inhibitor lornoxicam attenuated mechanical and thermal hyperalgesia induced by sciatic nerve chronic constriction injury and inhibited the increased expression of GAP-43 and NGF.

Wen-Luo-Tong Prevents Glial Activation and Nociceptive Sensitization in a Rat Model of Oxaliplatin-Induced Neuropathic Pain

Huangqi Guizhi Wuwu Decoction Alleviates Oxaliplatin-Induced Peripheral Neuropathy Via the Gut-Peripheral Nerve Axis.

Engagement of MicroRNA-155 in Exaggerated Oxidative Stress Signal and TRPA1 in the Dorsal Horn of the Spinal Cord and Neuropathic Pain During Chemotherapeutic Oxaliplatin

2-Bromopalmitate decreases spinal inflammation and attenuates oxaliplatin-induced neuropathic pain via reducing Drp1-mediated mitochondrial dysfunction

Molecular Mechanism of Electroacupuncture Treatment on Oxaliplatin-Induced Peripheral Neurotoxicity in Rats

Glial role in oxaliplatin-induced neuropathic pain

Wnt3a/YTHDF1 Regulated Oxaliplatin-Induced Neuropathic Pain Via TNF-α/IL-18 Expression in the Spinal Cord

Huangqi Guizhi Wuwu Decoction Can Prevent and Treat Oxaliplatin Induced Neuropathic Pain by TNFα/IL-1β/IL-6/MAPK/NF-kB Pathway

Transient Receptor Potential Channel and Interleukin-17A Involvement in LTTL Gel Inhibition of Bone Cancer Pain in a Rat Model

Neuroprotective effects and UPLC-Q-TOF/MS-based active components identification of external applied a novel Wen-Luo-Tong microemulsion

Behavioral and Immunohistological Assessment of Painful Neuropathy Induced by a Single Oxaliplatin Injection in the Rat

NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy

Downregulation of Metallothionein-2 Contributes to Oxaliplatin-Induced Neuropathic Pain

Curcumin relieves oxaliplatin‐induced neuropathic pain via reducing inflammation and activating antioxidant response

Effects of Cyclooxygenase 2 Inhibitor on Growth-Associated Protein 43 and Nerve Growth Factor Expression in Dorsal Root Ganglion During Neuropathic Pain Development

Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat.

The Upregulation Of Translocator Protein (18 Kda) Promotes Recovery From Neuropathic Pain In Rats

Effects of gabapentin on high-voltage-activated calcium currents in dorsal root ganglion neurons in mice with oxaliplatin-induced neuropathic pain

The inhibition of spinal synaptic plasticity mediated by activation of AMP-activated protein kinase signaling alleviates the acute pain induced by oxaliplatin

Overexpression of GDNF in Spinal Cord Attenuates Morphine Analgesic Tolerance in Rats with Bone Cancer Pain

Effect and Mechanism of Inhibition of PI3K/Akt/mTOR Signal Pathway on Chronic Neuropathic Pain and Spinal Microglia in a Rat Model of Chronic Constriction Injury.